From b4e59f6a8468ddc693bea8307e8abf0d6a85afb5 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 11 Mar 2024 10:23:02 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Posts.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index a2a4a10a..8d64ce48 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -3,7 +3,7 @@ - # REALISE study registration - ## Our first, and biggest, clinic trial is registered - #+BEGIN_VERSE - At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation ), our biggest clinical trial, has already been reviewed and approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry. + At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our most ambitious clinical trial, has already been reviewed and approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry. This clinical trial is a Cohort Event Study aimed at evaluating both safety and effectiveness within large populations. We expect to recruit around 20 thousand people. #+END_VERSE \ No newline at end of file